Genomic profile analysis of diffuse-type gastric cancers
Authors:
- Yeon-Su LeeYLYeon-Su Lee
- Yun Sung ChoYCYun Sung Cho
- Geon Kook LeeGLGeon Kook Lee
- Sunghoon LeeSLSunghoon Lee
- Young-Woo KimYKYoung-Woo Kim
- Sungwoong JhoSJSungwoong Jho
- Hak-Min KimHKHak-Min Kim
- Seung-Hyun HongSHSeung-Hyun Hong
- Jung-Ah HwangJHJung-Ah Hwang
- Sook-Young KimSKSook-Young Kim
- Dongwan HongDHDongwan Hong
- Il Ju ChoiICIl Ju Choi
Open Access
- 1 April 2014
- journal article
- research article
- Published by Springer Nature in Genome Biology
- Vol. 15 (4) , R55
Abstract
Background: Stomach cancer is the third deadliest among all cancers worldwide. Although incidence of the intestinal-type gastric cancer has decreased, the incidence of diffuse-type is still increasing and its progression is notoriously aggressive. There is insufficient information on genome variations of diffuse-type gastric cancer because its cells are usually mixed with normal cells, and this low cellularity has made it difficult to analyze the genome. Results: We analyze whole genomes and corresponding exomes of diffuse-type gastric cancer, using matched tumor and normal samples from 14 diffuse-type and five intestinal-type gastric cancer patients. Somatic variations found in the diffuse-type gastric cancer are compared to those of the intestinal-type and to previously reported variants. We determine the average exonic somatic mutation rate of the two types. We find associated candidate driver genes, and identify seven novel somatic mutations in CDH1, which is a well-known gastric cancer-associated gene. Three-dimensional structure analysis of the mutated E-cadherin protein suggests that these new somatic mutations could cause significant functional perturbations of critical calcium-binding sites in the EC1-2 junction. Chromosomal instability analysis shows that the MDM2 gene is amplified. After thorough structural analysis, a novel fusion gene TSC2-RNF216 is identified, which may simultaneously disrupt tumor-suppressive pathways and activate tumorigenesis. Conclusions: We report the genomic profile of diffuse-type gastric cancers including new somatic variations, a novel fusion gene, and amplification and deletion of certain chromosomal regions that contain oncogenes and tumor suppressors.Keywords
This publication has 78 references indexed in Scilit:
- Whole exome sequencing of pediatric gastric adenocarcinoma reveals an atypical presentation of Li‐Fraumeni syndromePediatric Blood & Cancer, 2012
- A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of ItalyClinical and Experimental Medicine, 2012
- Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinomaNature Genetics, 2011
- The genomic complexity of primary human prostate cancerNature, 2011
- The Extracellular Architecture of Adherens Junctions Revealed by Crystal Structures of Type I CadherinsStructure, 2011
- The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosisCell Death & Differentiation, 2010
- Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practiceGastric Cancer, 2010
- Targeted capture and massively parallel sequencing of 12 human exomesNature, 2009
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Mdm2 Gene Amplification in Gastric Cancer Correlation with Expression of Mdm2 Protein and p53 AlterationsLaboratory Investigation, 2000